.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Federal Trade Commission
Cipla
Covington
UBS
Cerilliant
Fuji
US Department of Justice
Express Scripts
AstraZeneca

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018300

« Back to Dashboard
NDA 018300 describes HIBISTAT, which is a drug marketed by Molnlycke Hlth and is included in one NDA. It is available from one supplier. Additional details are available on the HIBISTAT profile page.

The generic ingredient in HIBISTAT is chlorhexidine gluconate. There are fifty-seven drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.

Summary for NDA: 018300

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Dental and Oral Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 018300

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HIBISTAT
chlorhexidine gluconate
SOLUTION;TOPICAL 018300 NDA Mölnlycke Health Care US, LLC 0234-0587 0234-0587-17 50 PACKET in 1 CARTON (0234-0587-17) > 5 mL in 1 PACKET
HIBISTAT
chlorhexidine gluconate
SOLUTION;TOPICAL 018300 NDA Mölnlycke Health Care US, LLC 0234-0587 0234-0587-27 15 PACKET in 1 CARTON (0234-0587-27) > 5 mL in 1 PACKET

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION;TOPICALStrength0.5%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Chubb
Express Scripts
US Army
Daiichi Sankyo
Johnson and Johnson
Cipla
Citi
Baxter
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot